首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1560810

全球便携式血液透析市场 - 2024 - 2031

Global Portable Hemodialysis Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球便携式血液透析市场规模达到202亿美元，预计2031年将达到353.8亿美元，2024-2031年预测期间复合年增长率为7.4%。

血液透析是一种替代肾臟工作以清除血液中废物和多余液体的治疗。这是透过一种称为透析器或人工肾臟的特殊过滤器来完成的。血液通过塑胶管进入透析器，在那里进行清洁，然后返回患者体内。每次治疗开始时，将两根针插入通路中。这些针连接到将血液输送到透析器的塑胶管。任何时间只有少量血液从体内流出。透析机将血液泵入透析系统并控制治疗时间、温度、液体移除和压力。

便携式血液透析装置是一种医疗装置，其可以轻鬆地从一个位置移动到另一个位置，从而对患者有利并且可以将该装置携带到患者所在地。如今，肾臟疾病和病症正在以惊人的速度增加，这增加了对便携式血液透析产品的需求。

市场动态：

司机

慢性肾臟疾病盛行率增加

全球便携式血液透析市场的需求由多种因素驱动。慢性肾臟疾病盛行率的上升推动了市场的成长。

此外，技术进步的增加将推动对治疗的需求。例如，根据 nih.gov 报导，慢性肾臟病是一种进行性疾病，影响全球 10% 以上的总人口，总计超过 8 亿人。慢性肾病在老年人、女性、少数族裔以及患有糖尿病和高血压的人中更为常见。慢性肾臟病对低收入和中等收入国家来说是一个特别沉重的负担，而这些国家最没有能力应对其后果。

例如，根据美国国家肾臟基金会的数据，目前全球有超过 200 万人接受透析或肾臟移植治疗以维持生命，但这一数字可能只占真正需要治疗才能生存的人的 10%。据估计，在中国和印度等发展中国家，老年人口数量不断增加，肾衰竭病例数将不成比例地增加。在接受肾衰竭治疗的 200 万人中，大多数人仅在美国、日本、德国、巴西和义大利这五个国家接受治疗。这五个国家仅占世界人口的12%。在占世界人口 50% 以上的约 100 个发展中国家，只有 20% 的人得到治疗。

限制

与手术相关的併发症和人们缺乏意识等因素预计将阻碍市场。根据美国国家肾臟基金会统计，全球10%的人口受到慢性肾臟病的影响，慢性肾臟病是第12大常见死因。每年有数百万人因无法获得负担得起的治疗而死亡。

细分市场分析

全球便携式血液透析市场根据产品、泵浦系统、最终用户和地区进行细分。

该细分市场便携式设备约占全球便携式血液透析市场份额的49.7%

预计便携式设备领域将在预测期内占据最大的市场份额。在这一领域，技术进步以及私人製造商用于设备开发的资金不断增加将推动该市场的发展。

例如，2024年3月，总部位于荷兰Bussum的医疗科技公司Nextkidney宣布开发出全球第一台携带式血液透析设备Neokidney。据这家荷兰公司称，Neokidney 正处于最后开发阶段，预计将于 2024 年在荷兰推出。

此外，2024年8月，医疗器材製造商Synopex取得食品药物安全部（MFDS）的上市许可，为国内首个自主研发的重症监护病患连续性肾臟替代治疗（CRRT）设备。

市场地理分析

北美约占全球携带式血液透析市场份额的42.3%

预计北美地区将在预测期内占据最大的市场份额。该地区慢性肾臟病发病率的上升、技术的进步以及资金分配的增加有助于推动市场发展。

例如，根据美国肾臟基金会的统计，估计有 3550 万美国人患有肾臟疾病。大约 808,000 名美国人患有肾衰竭。超过 557,000 名美国人正在接受透析。肾臟疾病正以惊人的速度增长。目前，超过七分之一（或 14%）的美国成年人受到该疾病的影响，有色人种患肾衰竭的风险更大。 There were about 135,000 Americans newly diagnosed with kidney failure in 2021. 9 out of 10 people with kidney disease are unaware they have it, and 1 in 3 of those with severely reduced kidney function (but not yet on dialysis) are unaware they have kidney疾病.

此外，2023 年 9 月，AWAK Technologies 获得了超过 2,000 万美元的 B 轮融资，用于其在美国进行的可穿戴透析设备的关键试验。 AWAK PD 是一款超便携式腹膜透析 (PD) 系统，可让肾臟病患者在家中或在旅途中的任何地方接受透析。该公司将把所得款项用于各种重要倡议，以完成与新加坡中央医院正在进行的人体关键前临床研究。这笔资金还将帮助该公司改进超便携式 PD 设备，以进行预计 2025 年在美国开始的最终关键试验。

Hemodialysis is a treatment that replaces the work of one's kidneys to clear wastes and extra fluid from the blood. This is done using a special filter called a dialyzer or artificial kidney. The blood travels through plastic tubing to the dialyzer, where it is cleaned and then returned to the patient. At the beginning of each treatment, two needles are placed into the access. These needles are connected to the plastic tubing that carries the blood to the dialyzer. Only a small amount of blood is out from the body at any one time. The dialysis machine pumps the blood through the dialysis system and controls the treatment time, temperature, fluid removal, and pressure.

A portable hemodialysis device is a medical device, which can be moved from one location to another location easily so that it is beneficial for the patient and the device can be carried to the patient's location. Nowadays, kidney diseases and disorders are increasing at an alarming rate which is increasing the need for portable hemodialysis products.

Market Dynamics: Drivers

Increasing prevalence of chronic kidney disorders

The demand for the global portable hemodialysis market is driven by multiple factors. The rising prevalence of chronic kidney disorders propels the market growth.

Furthermore, the demand for treatment will be fueled by the increase in technological advancements. For instance, according to nih.gov, chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences.

For instance, according to the National Kidney Foundation, over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live. It is estimated that the number of cases of kidney failure will increase disproportionately in developing countries, such as China and India, where the number of elderly people is increasing. Of the 2 million people who receive treatment for kidney failure, the majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy. These five countries represent only 12% of the world's population. Only 20% are treated in about 100 developing countries that make up over 50% of the world population.

Restraints

Factors such as complications linked with the procedure and lack of awareness among people are expected to hamper the market. According to statistics from the National Kidney Foundation in the United States, 10 percent of the world's population is affected by chronic kidney disease and it is the 12th most common cause of death. Millions die annually due to a lack of access to affordable treatment.

Market Segment Analysis

The global portable hemodialysis market is segmented based on product, pumping system, end-user, and region.

The segment portable devices accounted for approximately 49.7% of the global portable hemodialysis market share

The portable devices segment is expected to hold the largest market share over the forecast period. In this segment, the technological advancements, and rising funds for private manufacturers for device development would drive this market.

For instance, in March 2024, Bussum, the Netherlands-based Nextkidney, a medtech company, announced that it has developed the world's first portable hemodialysis device, Neokidney. According to the Dutch company, Neokidney is in the final development phase and is expected to launch in the Netherlands by 2024.

Moreover, in August 2024, Synopex, a medical device manufacturer, obtained marketing authorization from the Ministry of Food and Drug Safety (MFDS) for the nation's first independently developed continuous renal replacement therapy (CRRT) device for critical care patients.

Market Geographical Analysis

North America accounted for approximately 42.3% of the global portable hemodialysis market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of chronic kidney diseases, technological advancements, and increase in fund allotment in this region, help to propel the market.

For instance, according to American Kidney Fund, An estimated 35.5 million Americans have kidney disease. About 808,000 Americans are living with kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is growing at an alarming rate. It currently affects more than 1 in 7 (or 14%) of American adults, with people of color at greater risk for kidney failure. There were about 135,000 Americans newly diagnosed with kidney failure in 2021. 9 out of 10 people with kidney disease are unaware they have it, and 1 in 3 of those with severely reduced kidney function (but not yet on dialysis) are unaware they have kidney disease.

Moreover, in September 2023, AWAK Technologies obtained more than $20m in Series B funding for the US-based pivotal trial of its wearable dialysis device. AWAK PD, the ultra-portable peritoneal dialysis (PD) system allows kidney disease patients to undergo dialysis at home and anywhere on the go. The company will use the proceeds for various crucial initiatives to conclude its ongoing human pre-pivotal clinical study with Singapore General Hospital. The funding will also help the company improve the ultraportable PD device for the final pivotal trial in the US, anticipated to begin in 2025.

Market Segmentation

By Product

Portable Devices

Consumables

Blood Lines

Dialyzer and Dialysate

Software and Services

Others

By Pumping System

Single Pump

Double Pump

By End-User

Hospitals

Specialty Clinics

Dialysis Centers

Homecare

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global portable hemodialysis market include NxStage Medical Inc., Quanta Dialysis Technologies, Cantel Medical Group of Companies, AWAK Technologies, Medtronic, SB Kawasumi Laboratories, Texas Instruments Incorporated., Baxter, Diality, and Teleflex Incorporated. among others.

Key Developments

In April 2023, AWAK Technologies, a Singapore-based medical technology company, recently received FDA Breakthrough Device designation for their wearable and portable dialysis device. The AWAK Peritoneal Dialysis device, or AWAK PD, uses AWAK's patented sorbent technology and offers a convenient means of dialysis for renal disease patients.

In June 2022, NextKidney recently announced that it had acquired Dialyss Pte. Ltd. to boost the development of its portable Neokidney hemodialysis device. NextKidney officials boast that the Neokidney will be a small, user-friendly, home hemodialysis device, using only 4 liters of fluid per session. In addition, they say that it can run entirely independent of water supply and drain, enabling people to use it anytime and anywhere.

Why Purchase the Report?

To visualize the global portable hemodialysis market segmentation based on product, pumping system, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global portable hemodialysis market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global portable hemodialysis market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Pumping System
3.2. Snippet by Product
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
  - 4.1.1.2. Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Complications Linked With Procedure
  - 4.1.2.2. Lack of Awareness
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Consumables
6.4. Software and Services
6.5. Others

7. By Pumping System

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 7.1.2. Market Attractiveness Index, By Pumping System
7.2. Single Pump*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Double Pump

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Dialysis Centers
8.5. Homecare
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pumping System
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. NxStage Medical Inc. *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Quanta Dialysis Technologies
11.3. Cantel Medical Group of Companies
11.4. AWAK Technologies
11.5. Medtronic
11.6. SB Kawasumi Laboratories
11.7. Texas Instruments Incorporated. Incorporated.
11.8. Baxter
11.9. Diality
11.10. Teleflex Incorporated. (*LIST NOT EXHAUSTIVE)